✦ LIBER ✦

Oral drug delivery systems using chemical conjugates or physical complexes

✍ Scribed by Al-Hilal, Taslim A. (author);Alam, Farzana (author);Byun, Youngro (author)

Book ID: 118178427
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 923 KB
Volume: 65
Category: Article
ISSN: 0169-409X
DOI: 10.1016/j.addr.2012.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral drug delivery systems using chemica

Oral drug delivery systems using chemical conjugates or physical complexes

✍ Al-Hilal, Taslim A. (author);Alam, Farzana (author);Byun, Youngro (author) 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 923 KB

Physical characterizations of microemuls

Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs

✍ Wen-Ting Ke; Shyr-Yi Lin; Hsiu-O Ho; Ming-Thau Sheu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 486 KB

Enhanced Oral Absorption of Paclitaxel i

Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors

✍ Shicheng Yang; R. Neslihan Gursoy; Gregory Lambert; Simon Benita 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 164 KB

Enhanced Oral Absorption of Paclitaxel i

Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or Without Concomitant Use of P-Glycoprotein Inhibitors

✍ Shicheng Yang; R. Neslihan Gursoy; Gregory Lambert; Simon Benita 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 164 KB

The objective of this study was to evaluate the pharmacokinetics of paclitaxel in a novel self-microemulsifying drug delivery system (SMEDDS) for improved oral administration with or without P-glycoprotein (P-gp) inhibitors. Methods. Paclitaxel SMEDDS formulation was optimized, in terms of droplet s

Recombinant conjugate antibody molecule

Recombinant conjugate antibody molecule modified to contain antigen moiety for its delivery to Ag-presenting cells of immune system; major histocompatibility complex class-I, class-II, dendrite cell or CD4+ cell monoclonal antibody-antigen fusion protein expression for use as a recombinant vaccine or diagnostic agent : Connaught Lab World 9640 941; 19 December 1996

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 229 KB